...
首页> 外文期刊>Journal of molecular graphics & modelling >Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P(1) receptor agonists
【24h】

Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P(1) receptor agonists

机译:对准独立的3D-QSAR研究和分子动力学模拟,用于鉴定有效和选择性S1P(1)受体激动剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sphingosine 1-phosphate type 1 (S1P(1)) receptors are expressed on lymphocytes arid regulate immune cells trafficking. Sphingosine 1-phosphate and its analogues cause internalization and degradation of SiP1 receptors, preventing the auto reactivity of immune cells in the target tissues. It has been shown that S1 Pi receptor agonists such as fingolimod can be suitable candidates for treatment of autoimmune diseases. The current study aimed to generate GRIND-based 3D-QSAR predictive models for agonistic activities of 2-imino-thiazolidin-4-one derivatives on S1P(1) to be used in virtual screening of chemical libraries. The developed model for the SiP1 receptor agonists showed appropriate power of predictivity in internal (r(acc)(2), 0.93 and SDEC 0.18) and external (r(2) 0.75 and MAE (95% data), 0.28) validations. The generated model revealed the importance of variables DRY-N1 and DRY-O in the potency and selectivity of these compounds towards SI Pi receptor. To propose potential chemical entities with S1P(1) agonistic activity, PubChem chemicals database was searched and the selected compounds were virtually tested for S1P(1) receptor agonistic activity using the generated models, which resulted in four potential compounds with high potency and selectivity towards S1P(1) receptor. Moreover, the affinities of the identified compounds towards S1P(1) receptor were evaluated using molecular dynamics simulations. The results indicated that the binding energies of the compounds were in the range of -39.31 to -46.18 and -3.20 to -9.75 kcal mol(-1), calculated by MM-GBSA and MM-PBSA algorithms, respectively. The findings in the current work may be useful for the identification of potent and selective S1P(1) receptor agonists with potential use in diseases such as multiple sclerosis. (C) 2019 Elsevier Inc. All rights reserved.
机译:鞘氨醇1-磷酸型1(S1P(1))受体在淋巴细胞干旱调节免疫细胞运输上表达。鞘氨醇1-磷酸盐及其类似物导致SIP1受体的内化和降解,防止靶组织中免疫细胞的自动反应性。已经证明,S1 PI受体激动剂如Fingolimod可以是适合治疗自身免疫疾病的候选者。目前的研究旨在产生基于研磨的3D-QSAR预测模型,用于2-亚氨基 - 噻唑嗪-4-One衍生物的激动活性在S1P(1)上用于化学文库的虚拟筛选。 SIP1受体激动剂的开发模型在内部(R(ACC)(2),0.93和SDEC 0.18)和外部(R(2)0.75和MAE(95%数据),0.28)验证中的适当功率。所产生的模型揭示了变量干-n1和干-O在这些化合物对Si pi受体的效力和选择性中的重要性。为了提出具有S1P(1)激动活动的潜在化学实体,搜索Pubchem Chemicals数据库,使用所产生的模型实际上测试所选化合物的S1P(1)受体激动活性,这导致具有高效力和选择性的四种潜在化合物S1P(1)受体。此外,使用分子动力学模拟评估所鉴定化合物朝向S1P(1)受体的亲和力。结果表明,化合物的结合能量分别为-39.31至-46.18和-3.20至-9.75kcal(-1),分别由mm-gbsa和mm-pbsa算法计算。目前工作中的发现可能对于鉴定有效和选择性S1P(1)受体激动剂的潜在用途是有用的,其潜在用途诸如多发性硬化症等疾病。 (c)2019 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号